Jeffrey Arcara insider trades
Open-market stock purchases and sales by Jeffrey Arcara, Chief Business Officer at Corvus Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 28, 2024.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 4, 2025 | CRVS Corvus Pharmaceuticals, Inc | Bought (not open market) | — |
Companies traded
- CRVS Corvus Pharmaceuticals, Inc: other filings, last Dec 4, 2025